<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="67781">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02223455</url>
  </required_header>
  <id_info>
    <org_study_id>CRE 12-289</org_study_id>
    <nct_id>NCT02223455</nct_id>
  </id_info>
  <brief_title>Building an Optimal Hand Hygiene Bundle</brief_title>
  <official_title>Building an Optimal Hand Hygiene Bundle: A Mixed Methods Approach</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Iowa City Veterans Affairs Medical Center</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Iowa City Veterans Affairs Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hand hygiene is the single most effective practice in preventing the spread of
      hospital-acquired infections. Despite the strength of the evidence, hospital staff continue
      to sanitize their hands less than half of the time required by guidelines. Effective
      interventions are needed to improve hand hygiene compliance rates among hospital staff, but
      most are of poor quality and do not examine the specific effects of individual
      interventions. This study will build a &quot;bundle&quot; of three hand hygiene interventions using a
      research design that allows for the effectiveness of each intervention to be measured
      individually and combined.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The two specific aims and associated hypotheses of CREATE Project 2 include:

        1. Identify combinations of hand-hygiene intervention strategies that optimize
           hand-hygiene compliance and that could form an evidence-based hand-hygiene bundle for
           Veterans Health Administration (VHA) implementation.

           Hypothesis 1: Combinations of interventions will increase compliance rates more than
           single interventions.

           Aim 1 will entail a 30-month cluster-randomized controlled trial that will sequentially
           test three individual hand-hygiene interventions - hand-hygiene point-of-use reminder
           signs to serve as an environmental cue to action, individual hand sanitizers, and
           health care worker hand cultures - to identify an optimal combination of interventions
           to increase hand-hygiene compliance. The trial will be conducted in 59 hospital units
           in 10 VA hospitals in order to test the efficacy of individual and then sequentially
           added interventions to determine their incremental impact on hand-hygiene compliance.

           The focus for this clinical trial will be on Aim 1--Single Hand Hygiene Sign changes.

        2. Identify institutional, organizational, ward/ICU, and individual level facilitators and
           barriers to implementing hand-hygiene interventions.

      Hypothesis 2: Facilitators and barriers will pattern around contextual factors such as level
      of leadership support and organization of infection control programs.

      Aim 2 will entail a qualitative process evaluation that includes site visits to purposefully
      selected sites, semi-structured interviews, and observations to examine barriers and
      facilitators to the interventions and develop contextual insight for implementing and
      scaling-up the intervention at additional sites as a national initiative.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2014</start_date>
  <completion_date type="Anticipated">March 2019</completion_date>
  <primary_completion_date type="Anticipated">August 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single Blind (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hand Hygiene Compliance</measure>
    <time_frame>phase 1 (7-12 months) thru phase 3 (19-21 months)</time_frame>
    <description>Hand hygiene compliance is the primary outcome measure. Compliance rates will be determined using the same methods of direct observation of HCWs developed by Dr. Perencevich for his VA Health Services Research &amp; Development (HSR&amp;D) funded study (IIR 09-099). Both compliance and MRSA infection rates will be collected monthly throughout the project for each of the 59 units.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>MRSA Acquisition</measure>
    <time_frame>phase 1 (7-12 months) thru phase 3 (19-21 months)</time_frame>
    <description>The secondary outcome measure is MRSA acquisition. MRSA infection rates will be collected monthly throughout the project for each of the 59 units.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">59</enrollment>
  <condition>Hand Hygiene</condition>
  <condition>MRSA - Methicillin Resistant Staphylococcus Aureus Infection</condition>
  <condition>Compliance</condition>
  <arm_group>
    <arm_group_label>Single Hand Hygiene Sign</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Wards/units in this arm of the study will have the same hand hygiene sign posted by the hand sanitizer dispensers outside each patient room. The sign will not change.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hand Hygiene Signs Changed Monthly</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Hand hygiene signs will be changed monthly on wards/units randomized to this arm of the study. Signs will be posted by the hand hygiene sanitizer outside each patient room.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hand Hygiene Signs Changed Weekly</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Hand hygiene signs will be changed weekly on wards/units randomized to this arm of the study. Signs will be posted by the hand hygiene sanitizer outside each patient room.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Hand Hygiene Compliance Signs</intervention_name>
    <description>Hand hygiene signs will not be changed (control) or change weekly/monthly on wards/units randomized to each of these study arms. Signs will be posted by the hand hygiene sanitizer outside each patient room.</description>
    <arm_group_label>Single Hand Hygiene Sign</arm_group_label>
    <arm_group_label>Hand Hygiene Signs Changed Monthly</arm_group_label>
    <arm_group_label>Hand Hygiene Signs Changed Weekly</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Wards/units at 10 VA medical centers ( 1. hand hygiene observations of healthcare
             works on these wards/units, 2. MRSA rates on each ward/unit as documented in patient
             electronic medical record)

          -  Health Care Workers (HCWs), Hospital Epidemiologists, Infection Control
             Professionals, and MRSA/Multi-Drug Resistance Organism (MDRO) Coordinators (Aim 2)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Heather S Reisinger, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Iowa City VA Health Care System</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Heather S Reisinger, PhD</last_name>
    <phone>319-338-0851</phone>
    <phone_ext>7715</phone_ext>
    <email>heather.reisinger@va.gov</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Cassie L Cunningham, MPH</last_name>
    <phone>319-338-0851</phone>
    <phone_ext>7708</phone_ext>
    <email>cassie.cunningham@va.gov</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Miami VA Health Care System</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33125</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gio Baracco, MD</last_name>
      <phone>305-575-7000</phone>
      <email>gio.baracco@va.gov</email>
    </contact>
    <investigator>
      <last_name>Gio Baracco, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Iowa City VA Health Care System</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52246</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heather S Reisinger, PhD</last_name>
      <phone>319-338-0581</phone>
      <phone_ext>7715</phone_ext>
      <email>heather.reisinger@va.gov</email>
    </contact>
    <contact_backup>
      <last_name>Cassie L Goedken, MPH</last_name>
      <phone>319-338-0581</phone>
      <phone_ext>7708</phone_ext>
      <email>cassie.goedken@va.gov</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>VA Maryland Health Care System</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniel Morgan, MD</last_name>
      <phone>410-605-7000</phone>
      <email>Daniel.morgan2@va.gov</email>
    </contact>
    <investigator>
      <last_name>Daniel Morgan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Boston VA Health Care System</name>
      <address>
        <city>West Roxbury</city>
        <state>Massachusetts</state>
        <zip>02132-4927</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kalpani Gupta, MD</last_name>
      <phone>617-232-9500</phone>
      <email>Kalpani.gupta@va.gov</email>
    </contact>
    <investigator>
      <last_name>Kalpani Gupta, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>VA Ann Arbor Health Care System</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48105-2303</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Suzanne Bradley, MD</last_name>
      <phone>734-769-7100</phone>
      <email>Suzanne.bradley2@va.gov</email>
    </contact>
    <investigator>
      <last_name>Suzanne Bradley, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Minneapolis VA Health Care System</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55417-2309</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joseph Thurn, MD</last_name>
      <phone>612-725-2000</phone>
      <email>Joseph.thurn@va.gov</email>
    </contact>
    <investigator>
      <last_name>Joseph Thurn, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>VA Nebraska-Western Iowa Health Care System</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68105-1850</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marvin Bittner, MD</last_name>
      <phone>402-346-8800</phone>
      <email>Marvin.bittner@va.gov</email>
    </contact>
    <investigator>
      <last_name>Marvin Bittner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Portland VA Medical Center</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Graeme Forrest, MD</last_name>
      <phone>503-220-8262</phone>
      <email>Graeme.forrest2@va.gov</email>
    </contact>
    <investigator>
      <last_name>Graeme Forrest, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>South Texas Veterans Health Care System</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229-4404</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jose Cadena-Zuluaga, MD</last_name>
      <phone>210-617-5300</phone>
      <email>Jose.Cadena-Zuluaga@va.gov</email>
    </contact>
    <investigator>
      <last_name>Jose Cadena-Zuluaga, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>VA Salt Lake City Health Care System</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84108</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Rubin, MD</last_name>
      <phone>801-582-1565</phone>
      <email>Michael.Rubin2@va.gov</email>
    </contact>
    <investigator>
      <last_name>Michael Rubin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2016</verification_date>
  <lastchanged_date>March 15, 2016</lastchanged_date>
  <firstreceived_date>August 20, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Iowa City Veterans Affairs Medical Center</investigator_affiliation>
    <investigator_full_name>Heather Schacht Reisinger</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Methicillin-resistant Staphylococcus aureus (MRSA)</keyword>
  <keyword>Infection Control (IC)</keyword>
  <keyword>Hospital-associated infections (HAI)</keyword>
  <keyword>Hand Hygiene (HH)</keyword>
  <keyword>Compliance</keyword>
  <keyword>Health Care Workers (HCWs)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Staphylococcal Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
